Stay updated with breaking news from Sam Samad. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the third quarter 2021 following the close of market on Thursday,...
/PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the third quarter 2021 following the close of market on Thursday,...
Illumina Inc (ILMN) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Illumina Inc (NASDAQ: ILMN) Operator Good day, ladies and gentlemen, and welcome to the Illumina First Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to introduce your host for today's conference call, Ms. Juliet Cunningham, VP, Illumina, Investor Relations. Please go ahead, Ms. Cunningham.SPONSORED: 10 stocks we like better than Illumina When investing geniuses David and Tom Gardner have a stock tip, it...
Operator Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2020 Illumina Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to introduce your host for today's conference call, Ms. Juliet Cunningham, VP, Illumina, Investor Relations. Juliet Cunningham -- Vice President, Investor Relations Good afternoon everyone, and welcome to our earnings call for the fourth quarter and full year 2020. During the call today, we will review the financial results released after the close of mar...
Illumina CFO on using genome tech to beat pandemic Sam Samad, finance leader of the biotech group, reveals the importance of taking big decisions critical to defeating the coronavirus outbreak by Lawrie Holmes - February 4, 2021 From the start of the coronavirus outbreak, technology from Illumina has been at work helping defeat the pandemic. As a result of two Chinese university teams using the US biotech’s sequencing equipment, the genome (or genetical material) of the coronavirus was published on January 10, 2020 and vaccines from Oxford University/AstraZeneca, Moderna and Pfizer-BioNt...